Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander D Borgsteede

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|May 26, 2019
Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patientsYuanyuan Wang, Muh Akbar Bahar, Anouk M E Jansen, et al.
International Journal of Clinical Pharmacy|July 17, 2014
Completeness of patient records in community pharmacies post-discharge after in-patient medication reconciliation: a before-after studyFatma Karapinar-Çarkıt, Ben R L van Breukelen, Sander D Borgsteede, et al.
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Frontiers in Pharmacology|October 15, 2024
A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactionsLeonie Bogaard, Kayan Tsoi, Bas van de Steeg, et al.
Drug Safety|January 14, 2018
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisRianne A Weersink, Margriet Bouma, David M Burger, et al.
BMC Health Services Research|October 23, 2019
The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series studyFatma Karapinar-Çarkıt, Sander D Borgsteede, Marjo J A Janssen, et al.
BMJ Open|October 14, 2016
Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinionRianne A Weersink, Margriet Bouma, David M Burger, et al.
Frontiers in Pharmacology|August 8, 2020
Development of Comprehensible Prescription Label Instructions: A Study Protocol for a Mixed-Methods ApproachEkram Maghroudi, Charlotte M J van Hooijdonk, Liset van Dijk, et al.
European Journal of Clinical Pharmacology|March 2, 2024
Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety dataMaaike M E Diesveld, Daniëlle W M Jacobs- Pijnenburg, Rianne A Weersink, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|May 26, 2019
Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patientsYuanyuan Wang, Muh Akbar Bahar, Anouk M E Jansen, et al.
International Journal of Clinical Pharmacy|July 17, 2014
Completeness of patient records in community pharmacies post-discharge after in-patient medication reconciliation: a before-after studyFatma Karapinar-Çarkıt, Ben R L van Breukelen, Sander D Borgsteede, et al.
British Journal of Clinical Pharmacology|January 28, 2021
No association between use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers prior to hospital admission and clinical course of COVID-19 in the COvid MEdicaTion (COMET) studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
European Journal of Hospital Pharmacy : Science and Practice|June 27, 2020
COvid MEdicaTion (COMET) study: protocol for a cohort studyRoos S G Sablerolles, Freija E F Hogenhuis, Melvin Lafeber, et al.
Frontiers in Pharmacology|October 15, 2024
A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactionsLeonie Bogaard, Kayan Tsoi, Bas van de Steeg, et al.
Drug Safety|January 14, 2018
Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver CirrhosisRianne A Weersink, Margriet Bouma, David M Burger, et al.
BMC Health Services Research|October 23, 2019
The effect of a pharmaceutical transitional care program on rehospitalisations in internal medicine patients: an interrupted-time-series studyFatma Karapinar-Çarkıt, Sander D Borgsteede, Marjo J A Janssen, et al.
BMJ Open|October 14, 2016
Evaluating the safety and dosing of drugs in patients with liver cirrhosis by literature review and expert opinionRianne A Weersink, Margriet Bouma, David M Burger, et al.
Frontiers in Pharmacology|August 8, 2020
Development of Comprehensible Prescription Label Instructions: A Study Protocol for a Mixed-Methods ApproachEkram Maghroudi, Charlotte M J van Hooijdonk, Liset van Dijk, et al.
European Journal of Clinical Pharmacology|March 2, 2024
Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety dataMaaike M E Diesveld, Daniëlle W M Jacobs- Pijnenburg, Rianne A Weersink, et al.
Pageof 6